Pulmonary involvement in patients with multiorgan Langerhans cell histiocytosis. Eight case studies and literature review

1. Horáček J. Primary pulmonary histiocytosis X. Cesk Patol 1975; 11: 210–213.

2. Bittenglova R, Pešek M, Mukenšnabl P et al. Granulomatóza z Langerhansových buněk. Stud Pneumol Phthiseol 2002; 62: 196–202.

3. Polák J, Fuchs B. Pulmonary histiocytosis X. Cesk Radiol 1987; 41: 289–300.

4. Rožánek P, Molnar V, Rešl M. Tři případy plicní granulomatózy z Langerhansových buněk. Lék Zpr Lék Fak Univ Karlovy Hr Králové 1998; 43: 127–132.

5. Skácel Z, Marel M, Vraštilová P et al. Histiocytóza z Langerhansových buněk. Přehled literatury a vlastní pozorování. Stud Pneumol Phthiseol 2000; 60: 150–156.

6. Kinkor Z. Severe pulmonary involvement in Erdheim-Chester disease (case report). Cesk Patol 2001; 37: 114–147.

7. Pacovská V, Bortlová A, Homolka J et al. Granulomatóza z Langerhansových buněk. Trendy Med 2002; 4: 59–61.

8. Kodet R, Elleder M, Šmelhaus V et al. Disseminated histiocytosis X. Cesk Patol 1984; 20: 19–26.

9. Drastík J. Histiocytosis X in otorhinolaryngology. Cesk Otolaryngol 1970; 19: 49–55.

10. Fassmann A, Horáček J, Šindekla Z et al. Histocytosis X classified as Hand-Schueller-Christian disease in the oral cavity. Cesk Stomatol 1982; 82: 32–37.

11. Hrubala D, Durovic E, Markovská N. Histiocytosis X. Prakt Zubn Lek 1984; 32: 73–75.

12. Adam Z, Pour L, Krejčí M et al. Histiocytóza z Langerhansových buněk u osob dospělého věku nemoc s mnoha tvářemi. Zkušenosti jednoho pracoviště a přehled projevů nemoci. Vnitř Lék 2008; 54: 1063–1081.

13. Anton M, Holoušova M, Řehůřek J et al. Histiocytoza X a dětská očnice. Čs Ophthal 1992; 48: 176–180.

14. Bláha M. The hemophagocytic syndrome. Vnitř Lék 2003; 49: 163–164.

15. Bunanská E, Stančoková T, Dluholucký S. Histiocytóza z Langerhansových buněk. Čes Slov Pediat 1998; 53: 18–19.

16. Kodet R, Zitková M. Morphologic and roentgenologic pulmonary findings in disseminated histiocytosis X. Cesk Pediatr 1985; 40: 634–638.

17. Kodetová D, Kodet R, Syrůček M et al. Sinus histiocytosis with massive lymphadenopathy – a disseminated form of the Rosai-Dorfman syndrome. Cesk Patol 1996; 32: 53–59.

18. Mlyncek M, Uharcek P, Durcanský D. Vulvar Langerhans’ cell histiocytosis: a case report. Acta Obstet Gynecol Scand 2006; 85: 753–755.

19. Mottl H, Ganevová M, Radvanská J et al. Treatment results of Langerhans cell histiocytosis with LSH II protocol. Cas Lek Cesk 2005; 144: 753–755.

20. Mottl H, Koutecký J, Ganevová M. Strategie léčby histiocytózy z Langerhansových buněk u dětí. Čes Slov Pediat 1994; 49: 81.

21. Mottl H, Mráček J Kabelka Z et al. Histiocytóza z Langerhansových buněk u dětí. Čs Pediat 1992; 47: 530–533.

22. Mottl H, Mrácek J, Kabelka Z et al. Langerhans-cell histiocytosis in children. Cesk Pediatr 1992; 47: 530–533.

23. Mottl H, Rob L, Stary J et al. Langerhans cell histiocytosis of vulva in adolescent. Int J Gynecol Cancer 2000; 17: 520–524.

24. Pazdera J, Cerný O, Jirava E et al. Histiocytosis X of Abt-Letterer-Siwe type with primary manifestation in the oral cavity in a 15-months-old child. Cesk Stomatol 1974; 74: 136–141.

25. Schwartz A, Zich P. Eosinophilic histiocytic granuloma of the vulva and cervix. Sb Lek 1989; 91: 1–4.

26. Smilek P, Krejčová B, Čada K et al. Histiocytóza z Langerhansových buněk, případ postižení spánkové kosti. Otorinolaryng Foniat 1994; 43: 263–265.

27. Ščudla V, Roček V, Dušek B et al. Multifokální eozinofilní granulom v dospělosti. Vnitř Lék 1987; 33: 1078–1086.

28. Šímová B, Mališ J, Neuwirt J. Klinické projevy histiocytózy z Langerhansových buněk. Zdrav Nov ČR Lék Listy 2003; 52: 18.

29. Tichy M Jr, Tichy M, Krč I et al. Multicentrická retikulohistiocytóza. Čes Slov Derm 1999; 74: 168–171.

30. Toušovská K, Slavík Z. Histiocytóza z Langerhansových buněk v dětském věku. Lék Zprav Lék Fak Univ Karlovy Hr Králové 1997; 42: 127–132.

31. Velková A. Changes in the periodontium in children. Cesk Stomatol 1975; 75: 180–184.

32. Krajicek BJ, Ryu JH, Hartman TE et al. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest 2009; 135: 1542–1549.

33. Kawase T, Hamazaki M, Ogura M et al. CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol 2005; 81: 323–329.

34. Lee JS, Ko GH, Kim HC et al. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci 2006; 21: 577–580.

35. Willman CL, Busque L, Griffith BB et al. Langerhans’-cell histiocytosis (histiocytosis X) – a clonal proliferative disease. N Engl J Med 1994; 331: 154–160.

36. Yu RC, Chu C, Buluwela L et al. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767–768.

37. Yousem SA, Colby TV, Chen YY et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25: 630–636.

38. Geissmann F, Dieu-Nosjean MC, Dezutter C et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002; 196: 417–430.

39. Geissmann F, Lepelletier Y, Fraitag S et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001; 97: 1241–1248.

40. Tazi A, Bonay M, Grandsaigne M et al. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993; 147: 1531–1536.

41. Tazi A, Bouchonnet F, Grandsaigne M et al. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 1993; 91: 566–576.

42. Tazi A, Bonay M, Bergeron A et al. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996; 51: 611–614.

43. Tazi A, Montcelly L, Bergeron A et al. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 1998; 157: 2007–2010.

44. Tazi A, Moreau J, Bergeron A et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999; 163: 3511–3515.

45. Arrighi JF, Soulas C, Hauser C et al. TNF-a induces the generation of Langerin/(CD207)+ immature Langerhans-type dendritic cells from both CD14–CD1a and CD14+CD1a– precursors derived from CD34+ cord blood cells. Eur J Immunol 2003; 33: 2053–2063.

46. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767–811.

47. Brabencova E, Tazi A, Lorenzato M et al. Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells. Am J Pathol 1998; 152: 1143–1149.

48. Nagarjun Rao R, Moran CA, Suster S. Histiocytic disorders of the lung. Adv Anat Pathol 2010; 17: 12–22.

49. Hance AJ, Basset F, Saumon G et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann NY Acad Sci 1986; 465: 643–656.

50. Banchereau J, Paczesny S, Blanco P et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann NY Acad Sci 2003; 987: 180–187.

51. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255–258.

52. Valladeau J, Duvert-Frances V, Pin JJ et al. The monoclonal antibody DCGM4 recognizes langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999; 29: 2695–2704.

53. Vassallo R, Jensen EA, Colby TV et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.

54. Kambouchner M, Basset F, Marchal J et al. Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 2002; 166: 1483–1490.

55. Watanabe R, Tatsumi K, Hashimoto S et al. Respiratory Failure Research Group of Japan. Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 2001; 40: 998–1003.

56. Egeler RM, Neglia JP, Puccetti DM et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865–873.

57. Neumann MP, Frizzera G. The coexistence of Langerhans’ cell granulomatosis and malignant lymphoma may take different forms: report of seven cases with a review of the literature. Hum Pathol 1986; 17: 1060–1065.

58. Unger J, England D, Collins J. Miliary nodules, Hodgkin’s disease, and eosinophilic granuloma. J Thorac Imaging 1994; 9: 71–73.

59. Gaensler E, Carrington C. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30: 411–426.

60. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983; 14: 847–856.

61. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg 2001; 56: 163–172.

62. Kim CK, Park CB, Jin U et al. Pulmonary Langerhans’ cell histiocytosis presented with recurrent pneumothorax. Interact Cardiovasc Thorac Surg 2006; 5: 512–513.

63. Krawczyk P, Czekajska-Chehab E, Kieszko R et al. Difficulties in the diagnosis of rare immunological diseases manifesting with cystic lung disease and spontaneous pneumothorax: case reports. Heart Lung 2004; 33: 21–25.

64. Mendez JL, Nadrous HF, Vassallo R et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125: 1028–1032.

65. Minghini A, Trogdon SD. Recurrent spontaneous pneumothorax in pulmonary histiocytosis X. Am Surg 1998; 64: 1040–1042.

66. Knight RK. Haemoptysis in eosinophilic granuloma. Br J Dis Chest 1979; 73: 181–186.

67. Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J 2006; 27: 1272–1285.

68. Yağci B, Varan A, Cağlar M et al. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center. Pediatr Hematol Oncol 2008; 25: 399–408.

69. Lieberman PH, Jones CR, Steinman RM et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996; 20: 519–552.

70. Ryu JH, Colby TV, Hartman TE et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122–132.

71. ten Velde GP, Thunnissen FB, van Engelshoven JM et al. A solitary pulmonary nodule due to eosinophilic granuloma. Eur Respir J 1994; 7: 1539–1540.

72. Brambilla E, Fontaine E, Pison CM et al. Pulmonary histiocytosis X with mediastinal lymph node involvement. Am Rev Respir Dis 1990; 142: 1216–1218.

73. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans’ cell histiocytosis. Thorax 2000; 55: 405–416.

74. Vassallo R, Limper AH. Pulmonary Langerhans’ cell histiocytosis. Semin Respir Crit Care Med 2002; 23: 93–101.

75. Vassallo R, Ryu JH, Colby TV et al. Pulmonary Langerhans’-cell histiocytosis. N Engl J Med 2000; 342: 1969–1978.

76. Vassallo R, Ryu JH, Schroeder DR et al. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med 2002; 346: 484–490.

77. Vassallo R, Ryu JH. Pulmonary Langerhans‘ cell histiocytosis. Clin Chest Med 2004; 25: 561–571.

78. Sundar KM, Gosselin MV, Chung HL et al. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 2003; 123: 1673–1683.

79. Lin MW, Chang YL, Lee YC et al. Pulmonary Langerhans cell histiocytosis. Lung 2009; 187: 261–262.

80. Brauner MW, Grenier P, Mouelhi MM et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172: 255–258.

81. Brauner MW, Grenier P, Tijani K et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997; 204: 497–502.

82. Pipavath S, Godwin JD. Imaging of interstitial lung disease. Clin Chest Med. 2004; 25: 455–465.

83. Moore AD, Godwin JD, Müller NL et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989; 172: 249–254.

84. Vrielynck S, Mamou-Mani T, Emond S et al. Diagnostic value of high-resolution CT in the evaluation of chronic infiltrative lung disease in children. AJR Am J Roentgenol 2008; 191: 914–920.

85. Soler P, Bergeron A, Kambouchner M et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med 2000; 162: 264–270.

86. Aricò M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 247–258.

87. Aricò M, Haupt R, Russotto VS et al. Langerhans cell histiocytosis in two generations: a new family and review of the literature. Med Pediatr Oncol 2001; 36: 314–316.

88. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981; 60: 385–396.

89. Crausman RS, Jennings CA, Tuder RM et al. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996; 153: 426–435.

90. Basset F, Corrin B, Spencer H et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118: 811–820.

91. Schönfeld N, Frank W, Wenig S et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60: 38–44.

92. Schönfeld N. Pulmonary Langerhans cell histiocytosis. Pneumologie 2003; 57: 159–165.

93. Travis WD, Borok Z, Roum JH et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17: 971–986.

94. Wall CP, Gaensler EA, Carrington CB et al. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981; 123: 280–285.

95. Housini I, Tomashefski JF Jr, Cohen A et al. Transbronchial biopsy in patients with pulmonary eosinophilic granuloma. Comparison with findings on open lung biopsy. Arch Pathol Lab Med 1994; 118: 523–530.

96. Mayer J, Skřičková J, Vorlíček J. Postižení plic u imunokompromitovaných nemocných. Diferenciální diagnostika a využití bronchoalveolární laváže. Brno: Institut pro další vzdělávání pracovníků ve zdravotnictví 1995.

97. Hance AJ. Pulmonary immune cells in health and disease: dendritic cells and Langerhans’ cells. Eur Respir J 1993; 6: 1213–1220.

98. Soler P, Moreau A, Basset F et al. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989; 139: 1112–1117.

99. Casolaro MA, Bernaudin JF, Saltini C et al. Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988; 137: 406–411.

100. Auerswald U, Barth J, Magnussen H. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991; 169: 305–309.

101. Chollet S, Soler P, Dournovo P et al. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984; 115: 225–232.

102. Colasante A, Poletti V, Rosini S et al. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung. Am Rev Respir Dis 1993; 148: 752–759.

103. Takizawa Y, Taniuchi N, Ghazizadeh M et al. Bronchoalveolar lavage fluid analysis provides diagnostic information on pulmonary Langerhans cell histiocytosis. J Nippon Med Sch 2009; 76: 84–92.

104. Tötsch M, Guzman J, Theegarten D et al. Bronchoalveolar lavage. Pathologe 2007; 28: 346–353.

105. Zeppa P, Cozzolino I, Russo M et al. Pulmonary langerhans cell histiocytosis (histiocytosis X) on bronchoalveolar lavage: a report of 2 cases. Acta Cytol 2007; 51: 480–482.

106. Krenács L, Tiszalvicz L, Krenács T et al. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 1993; 171: 99–104.

107. Wang CW, Colby TV. Histiocytic lesions and proliferations in the lung. Semin Diagn Pathol 2007; 24: 162–182.

108. Emile JF, Wechsler J, Brousse N et al. Langerhans’ cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995; 19: 636–641.

109. Howarth DM, Gilchrist GS, Mullan BP et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85: 2278–2290.

110. Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54: 254–264.

111. Muzzi L, Pini Prato GP, Ficarrat G. Langerhans’ cell histiocytosis diagnosed through periodontal lesions: a case report. J Periodontol 2002; 73: 1528–1533.

112. Nagai S. Pulmonary Langerhans’ cell histiocytosis (LCH): epidemiology and clinical courses. Intern Med 2001; 40: 981–982.

113. Ouyang DL, Roberts BK, Gibbs IC et al. Isolated Langerhans cell histiocytosis in an adult with central diabetes insipidus: case report and review of literature. Endocr Pract 2006; 12: 660–663.

114. Powers MA, Askin FB, Cresson DH. Pulmonary eosinophilic granuloma. 25-year follow-up. Am Rev Respir Dis 1984; 129: 503–507.

115. Unel SY, Ozaslan H, Solmaz D et al. Reversible pulmonary Langerhans’ cell histiocytosis. JBR-BTR 2009; 92: 172–173.

116. Valliani L, Kanwar VS, Schwartz A. Isolated pulmonary Langerhans cell histiocytosis with recurrent bilateral pneumothoraces treated with chemotherapy and chemical pleurodesis. Pediatr Blood Cancer 2009; 53: 128–129.

117. Marten K. Smoking-related interstitial lung diseases. Rofo 2007; 179: 268–275.

118. Mogulkoc N, Veral A, Bishop PW et al. Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999; 115: 1452–1455.

119. Negrin-Dastis S, Butenda D, Dorzee J e al. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J 2007; 14: 235–237.

120. Tomashefski JF, Khiyami A, Kleinerman J. Neoplasms associated with pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1991; 115: 499–506.

121. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987; 1: 208–209.

122. Pappas CA, Rheinlander HF, Stadecker MJ. Pleural effusion as a complication of solitary eosinophilic granuloma of the rib. Hum Pathol 1980; 11: 675–677.

123. Delobbe A, Durieu J, Duhamel A et al. Groupe d’Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Eur Respir J 1996; 9: 2002–2006.

124. Fartoukh M, Humbert M, Capron F et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216–223.

125. Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997; 29: 157–166.

126. Hamada K, Teramoto S, Narita N et al. Pulmonary veno-occlusive disease in pulmonary Langerhans’ cell granulomatosis. Eur Respir J 2000; 15: 421–423.

127. Lombard CM, Medeiros LJ, Colby TV. Pulmonary histiocytosis X and carcinoma. Arch Pathol Lab Med 1987; 111: 339–341.

128. Sadoun D, Vaylet F, Valeyre D et al. Bronchogenic carcinoma in patients with pulmonary histiocytosis X. Chest 1992; 101: 1610–1613.

129. Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumours: association with pulmonary Langerhans cells. Pathology 1995; 27: 247–254.

130. Von Essen S, West W, Sitorius M et al. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990; 98: 765–767.

131. Malpas JS. Langerhans cell histiocytosis in adults. Hematol Oncol Clin North Am 1998; 12: 259–268.

132. Boehler A. Lung transplantation for cystic lung diseases: lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis. Semin Respir Crit Care Med 2001; 22: 509–515.

133. Sulica R, Teirstein A, Padilla ML. Lung transplantation in interstitial lung disease. Curr Opin Pulm Med 2001; 7: 314–322.

134. Etienne B, Bertocchi M, Gamondes JP et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998; 157: 288–291.

135. Gabbay E, Dark JH, Ashcroft T et al. Recurrence of Langerhans’ cell granulomatosis following lung transplantation. Thorax 1998; 53: 326–327.

136. Habib SB, Congleton J, Carr D et al. Recurrence of recipient Langerhans’ cell histiocytosis following bilateral lung transplantation. Thorax 1998; 53: 323–325.

137. Kasmani R, Narwal-Chadha R, Naveed S et al. Isolated pulmonary Langerhans cell histiocytosis. QJM 2009; 102: 741–742.

138. Konno S, Hizawa N, Betsuyaku T et al. Adult Langerhans cell histiocytosis with independently relapsing lung and liver lesions that was successfully treated with etoposide. Intern Med 2007; 46: 1231–1235.

139. Koschel D, Müller-Wening D. Pulmonary Langerhans-cell histiocytosis. Med Klin (Munich) 2003; 98: 461–463.

140. Lacronique J, Roth C, Battesti JP et al. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Torax 1982; 37: 104–109.

141. Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood 1999; 93: 4125–4130.

142. Pardanani A, Phyliky RL, Li CY et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003; 78: 301–306.

143. Goh NS, McDonald CE, MacGregor DP et al. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology 2003; 8: 91–94.

144. Lazor R, Etienne-Mastroianni B, Khouatra C et al. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax 2009; 64: 274–275.

145. Weitzman S, Braier J, Donadieu J et al. 2’-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009; 53: 1271–1276.

146. von Stebut E, Schadmand-Fischer S, Bräuninger W et al. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine and vinblastine. Arch Dermatol 2008; 144: 649–653.

147. Henter JI, Karlén J, Calming U et al. Successful treatment of Langerhans’-cell histiocytosis with etanercept. N Engl J Med 2001; 345: 1577–1578.

148. McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48: 44–49.

149. Rodríguez HN, García I, Alba A et al. Infliximab-induced reactivated Langerhan’s cell histiocytosis in a patient with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1286–1287.

150. Calming U, Jacobsson H, Henter JI. Detection of Langerhans cell histiocytosis lesions with somatostatin analogue scintigraphy – a preliminary report. Med Pediatr Oncol 2000; 35: 462–467.

151. Weinmann P, Crestani B, Tazi A et al. 111In-pentetreotide scintigraphy in patients with Langerhans’ cell histiocytosis. J Nucl Med 2000; 41: 1808–1812.

152. Lastoria S, Montella L, Catalano L et al. Functional imaging of Langerhans cell histiocytosis by 111In-DTPA-D-Phe(1)-octreotide scintigraphy. Cancer 2002; 94: 633–640.

153. Weiss SE, O’Connor L, Welsh JS. Refinement of radiation therapy based on PET data in an adult with Langerhans cell histiocytosis of soft tissues. Clin Adv Hematol Oncol 2006; 4: 290–292.

154. Steiner M, Prayer D, Asenbaum S et al. Modern imaging methods for the assessment of Langerhans’ cell histiocytosis-associated neurodegenerative syndrome: case report. J Child Neurol 2005; 20: 253–257.

155. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of bone marrow. Semin Musculoskelet Radiol 2009; 13: 120–133.

156. Derenzini E, Fina MP, Stefoni V et al. MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol 2010; 21: 1173–1178.

157. Phillips M, Allen C, Gerson P et al. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009; 52: 97–101.

158. Ribeiro MJ, Idbaih A, Thomas C et al. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis: results and potential interest for an early diagnosis of the disease. J Neurol 2008; 255: 575–580.

159. Arnaud L, Malek Z, Archambaud F et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 2009; 60: 3128–3138.

160. Tan IB, Padhy AK, Thng CH et al. Intensely hypermetabolic extra-axial brainstem tumor in Erdheim-Chester disease. Clin Nucl Med 2009; 34: 604–607.

161. Takahashi T, Yoshimoto M, Kondoh N. Spontaneously regressed Langerhans cell histiocytosis of lymph nodes in an elderly patient. Intern Med 2007; 46: 1757–1760.

162. Kaste SC, Rodriguez-Galindo C, McCarville ME et al. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007; 37: 615–622.

163. Binkovitz LA, Olshefski RS, Adler BH. Coincidence FDG-PET in the evaluation of Langerhans’ cell histiocytosis: preliminary findings. Pediatr Radiol 2003; 33: 598–602.

164. Blum R, Seymour JF, Hicks RJ. Role of FDG-positron emission tomography scanning in the management of histiocytosis. Leukem Lymphoma 2002; 43: 2155–2157.

165. Calming U, Bemstrand C, Mosskin M et al. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. J Pediatr 2002; 141: 435–440.

166. Aoki J, Watanabe H, Shinozaki T et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219: 774–777.

167. Giovanella L, Ceriani L, Crippa S et al. Imaging in endocrinology: Langerhans cell histiocytosis of the thyroid gland detected by 18FDG-PET/CT. J Clin Endocrinol Metab 2007; 92: 2866–2867.

168. Büchler T, Cervinek L, Belohlavek O et al. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 2005; 44: 286–288.

169. Feurestein IM, Archer A, Pluda JM et al. Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation. Radiology 1990; 174: 697–702.

170. Khoor A, Myers JL, Tazelaar HD et al. Pulmonary Langerhans cell histiocytosis presenting as a solitary nodule. Mayo Clin Proc 2001; 76: 209–211.

171. Fichter J, Doberauer C, Seegenschmiedt H. Langerhans cell histiocytosis in adults: An interdisciplinary challenge. Dtsch Arztebl 2007; 104: A2347–A2353.